Jun Lee

Jun Lee is a highly experienced professional in clinical science with a strong background in neurobiology and gene therapy. Currently serving as the Director of Clinical Science at Solid Biosciences, Jun has previously held key positions at Prothena Corporation plc, Taysha Gene Therapies, and Astellas Gene Therapies, where significant contributions included leading clinical development for Alzheimer's Disease studies and AAV9-based gene therapy projects for rare neurodegenerative diseases. An expert in clinical trial execution, regulatory compliance, and cross-functional collaboration, Jun has authored numerous clinical documents and established strategic relationships with key opinion leaders and study sites. Jun's academic credentials include a PhD in Neurobiology from the Friedrich Miescher Institute and postdoctoral research at UC San Diego, complemented by certifications in Biotechnology Project Management and Regulatory Affairs.